Gilman Hill Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Gilman Hill Asset Management, LLC
- $552 Million
- Q2 2024
A detailed history of Gilman Hill Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 5,123 shares of REGN stock, worth $5.8 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
5,123
Previous 4,892
4.72%
Holding current value
$5.8 Million
Previous $4.71 Million
14.36%
% of portfolio
0.98%
Previous 0.84%
Shares
18 transactions
Others Institutions Holding REGN
# of Institutions
1,460Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$10.2 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$9.56 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$9.37 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.48 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$5.25 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $121B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...